Here, by secretome analysis of hepatocyte and liver cancer cell lines, we identify a secreted tumor suppressor, PRSS35, that inhibits HCC progression through cleavage of the chemokine CXCL2, which mediates pro-tumor neutrophil function. Here, CXCL2 is linked to hepatocellular carcinoma.